WRS Westar Energy Westar Energy First Mortgage Bonds 6.10% Series Due May 15, 2047

INDIANAPOLIS, May 8 /PRNewswire-FirstCall/ -- Windrose Medical Properties Trust (NYSE:WRS), a self-managed specialty medical properties REIT, announced today that the underwriters of the Company's recent public offering have exercised the over-allotment option to purchase 299,277 shares of common stock at the public offering price of $14.80 per share. The closing of the over-allotment option occurred on May 4, 2006. As a result of the exercise, the Company received additional net proceeds, after underwriting discounts and commissions, of approximately $4.2 million, which resulted in total net proceeds from the offering of approximately $36.6 million. Robert W. Baird & Co. was sole-book runner and Raymond James & Associates, Inc. was co-manager. Copies of the prospectus supplement relating to the offering may be obtained by contacting Robert W. Baird & Co. Incorporated, 777 East Wisconsin Avenue, Milwaukee, WI 53201. This press release shall not constitute an offer to sell or the solicitation of an offer to buy nor shall there be any sale or an offer to buy these securities in any state in which such offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of any such state. About Windrose Windrose is a self-managed real estate investment trust (REIT) based in Indianapolis, Indiana with offices in Nashville, Tennessee. Windrose was formed to acquire, selectively develop and manage specialty medical properties, such as medical office buildings, ambulatory surgery centers, outpatient treatment and diagnostic facilities, and specialty hospitals and treatment centers. Safe Harbor Some of the statements in this news release, including those related to this offering and use of proceeds, constitute forward-looking statements. Such statements include, in particular, statements about our beliefs, expectations, plans and strategies that are not based on historical facts. You should not rely on our forward-looking statements because the matters they describe are subject to known and unknown risks, uncertainties, assumptions and changes in circumstances, many of which are beyond our control, which may cause our actual results to differ significantly from those expressed in any forward- looking statement. The factors that could cause actual results to differ materially from current expectations include our ability to complete this offering, our ability to deploy the net proceeds from this offering, adverse changes in healthcare laws, changes in economic and general business conditions, competition for specialty medical properties, our ability to finance our operations, regulatory conditions and other factors described from time to time in filings we make with the Securities and Exchange Commission. The forward-looking statements contained herein represent our judgment as of the date hereof, and we caution readers not to place undue reliance on such statements. We do not undertake to publicly update or revise any forward- looking statement whether as a result of new information, future events or otherwise. Contact: Investors/Media: Windrose Medical Properties Trust The Ruth Group Fred Farrar Stephanie Carrington/Jason Rando President and COO 646 536-7017/7025 317 860-8213 DATASOURCE: Windrose Medical Properties Trust CONTACT: Fred Farrar, President and COO, Windrose Medical Properties Trust, +1-317-860-8213; Investors, Media, Stephanie Carrington, +1-646-536-7017, , or Jason Rando +1-646-536-7025, , both of The Ruth Group

Copyright